Schedule a Meeting
Download Brochure
Table of Content
Get a Price
February 2025
The global bipolar disorder treatment market size was calculated at USD 9.74 billion in 2025 and is predicted to reach around USD 15.67 billion by 2034, expanding at a CAGR of 5.43% from 2025 to 2034. Increasing prevalence of bipolar disorder due to changes in lifestyle and rapid urbanization. Additionally, the government initiatives for increasing awareness and improved medical facilities propel the growth of the bipolar disorder treatment market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Bipolar disorder, also known as manic-depressive illness, is a mental health condition that causes significant alterations in an individual's mood, energy levels, activity, and concentration. People with bipolar disorder commonly experience cycles of high energy, enthusiasm, irritability, or an uplifted mood and separate intervals of feeling down, unhappy, indifferent, or despairing. Bipolar disorder can develop as a result of a combination of genetic and environmental factors, with stress or emotional trauma potentially triggering its onset. The growing prevalence of bipolar disorder is also linked to modern lifestyle changes and more demanding work environments. Additionally, greater awareness of the condition, driven by efforts from governments and NGOs, has led to more individuals seeking medical attention for diagnosis and treatment of their mental health issues. Moreover, considerable funding from top medical organizations in the research and development of bipolar disorder and its therapies has been essential in fueling the expansion of the market.
The Mental Health Gap Action Programme (mhGAP) by the World Health Organization operates in more than 100 countries, providing evidence-based guidelines, tools, and training resources to improve skills and increase access to treatment for major mental health disorders, such as bipolar disorder. This initiative emphasizes providing care in general settings, especially in low- and middle-income countries (LMICs).
Artificial intelligence (AI) and machine learning (ML) algorithms have become an indispensable part of the healthcare sector, driving the latest innovations. AI and ML are poised to transform the bipolar disorder treatment landscape by advancing diagnosis, customizing care, and elevating patient monitoring. AI and ML can identify early indicators of the condition by examining behavioral, genetic, and environmental information, allowing for earlier interventions. ML models can assist in tailoring treatment plans by forecasting patient reactions to medications and fine-tuning dosages. In pharmaceuticals, AI and ML speed up the identification of new therapies, enhancing the efficiency of the process. Wearable devices and applications powered by AI monitor patients' emotions and actions instantly, offering crucial information for prompt modifications. These technologies enhance access to care via telemedicine.
Increasing Incidence of Bipolar Disorder
The increasing occurrence of bipolar disorder, shaped by lifestyle, environmental, and genetic influences, is boosting the need for effective therapies. With growing awareness of mental health concerns, more people are pursuing a diagnosis and ongoing therapy, frequently incorporating medication. Moreover, enhanced early detection techniques and increased acceptance of mental health issues are leading to elevated diagnosis rates. The expanding patient population has resulted in an increased need for a range of medications, such as mood stabilizers, antipsychotics, and antidepressants. In reaction to this trend, pharmaceutical firms are significantly investing in research to create new drugs, driving market expansion.
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 indicates that mental illnesses remain one of the leading 10 conditions that contribute to the worldwide disease burden. Bipolar disorder, specifically, ranks among the most incapacitating mental health conditions.
Side effects linked with the medication
The side effects linked with medication for bipolar disorder treatment may somewhat impede market growth, as patients frequently hesitate to begin therapy because of worries about these effects. For example, medications such as Divalproex sodium and lithium, often used to treat bipolar disorder, may lead to side effects including nausea, tremors, sexual dysfunction, weight gain, memory problems, muscle weakness, thyroid issues, damage to the liver, and kidneys, and skin reactions, among others. Additionally, healthcare professionals might be reluctant to prescribe specific drugs with recognized side effects, potentially restricting the range of treatment alternatives and hindering market expansion.
Technological Development
Technological developments are significantly contributing to the expansion of the bipolar disorder treatment market. Advancements in diagnostic technologies, including AI and machine learning, enable earlier and more precise identification of bipolar disorder, resulting in prompt interventions. Wearable gadgets and mobile applications that monitor mood, sleep habits, and various health indicators assist in the constant observation of patients, facilitating immediate modifications to their treatment. Moreover, progress in telemedicine has increased the accessibility of mental health services, particularly for those in isolated regions. In terms of treatment, innovative drug delivery systems and customized therapies are enhancing outcomes by providing more efficient and personalized approaches for managing bipolar disorder. These technological advancements are not only improving patient care but are also aiding in the overall growth of the market.
Pear Therapeutics' reSET-O, a mobile application providing digital therapy for mental well-being, is being modified for the treatment of bipolar disorder to assist patients in conjunction with conventional therapies. These advancements are enhancing diagnosis and treatment, fueling market growth.
By drug class, the antipsychotics segment held a dominant presence in the market in 2024. The increasing diagnosis of bipolar disorder and other mental health conditions has led to a higher demand for medications that address symptoms like delusions, hallucinations, and mood swings. Additionally, advancements in drug formulations, particularly the development of long-acting injectables (LAIs), have significantly contributed to the growth of this market segment. These newer drug forms offer improved stability and enhance patient adherence to treatment. Antipsychotic medications have become essential in managing bipolar disorder due to their effectiveness in regulating mood and reducing the intensity of manic or depressive episodes. Key antipsychotics used for bipolar disorder include Seroquel, Olanzapine, and Aripiprazole. These medications have been vital in long-term treatment strategies and are commonly included in comprehensive care plans, often alongside mood stabilizers.
For instance,
By drug class, the antidepressants segment is projected to expand rapidly in the market in the coming years. The introduction of new drug formulations, such as oral tablets, has significantly boosted the market by enhancing the efficiency and effectiveness of treatments for mental health conditions. Antidepressant medications, in particular, have demonstrated their effectiveness in treating depression and other forms of bipolar disorder. As targeted treatments, antidepressants are valuable for managing bipolar disorder, offering a focused approach to care. Moreover, these drugs generally have fewer side effects, making them a more tolerable and preferable option for patients.
By distribution channel, the hospital pharmacies segment held the largest share of the bipolar disorder treatment market in 2024. The growth of this market can be linked to the rising number of individuals seeking mental health diagnoses. Increased awareness, driven by efforts from both government and non-government organizations(NGOs), has led more people to seek medical assistance. The WHO's QualityRights program aims to improve care quality and maintain human rights standards in mental health and social care settings. It also enables organizations to support the welfare of individuals facing mental health challenges, such as bipolar disorder. This has, in turn, boosted the demand for medications in hospital pharmacies. Patients often prefer hospital pharmacies due to their reliability, convenience, and strong connection to the healthcare system. These factors have contributed to the positive expansion of this market segment.
By distribution channel, the online pharmacies segment is projected to grow with the fastest CAGR in the market during the forecast period due to the ability to conveniently request medications from home, often at reduced costs, eliminating the necessity for regular visits to local pharmacies. The growth of e-commerce and heightened awareness of mental health have led to a higher demand for online platforms. Furthermore, the round-the-clock accessibility of these pharmacies enhances their attractiveness, establishing them as a favored option for numerous patients dealing with chronic conditions such as bipolar disorder.
North America dominated the global bipolar disorder treatment market in 2024. This increase can be linked to the growing incidence of bipolar disorder and the existence of notable medical facilities in the area. The rise of urbanization and a more demanding environment has resulted in more individuals pursuing mental health care. Government efforts to raise awareness about mental health have made this achievable. Furthermore, alterations in lifestyle and increased levels of substance use have also played a role in the growth of the market in this sector.
The U.S. held a dominance of the bipolar disorder market in North America, driven by its advanced medical infrastructure and a growing number of patients seeking treatment for mental health conditions. The high-stress environment, along with rising substance abuse and unhealthy lifestyle choices, has led to a surge in mental health diagnoses across the country. Additionally, the presence of major pharmaceutical companies has contributed to market growth by providing a wide range of treatment options for bipolar disorder.
The market for bipolar disorder treatment in Canada is expanding due to heightened awareness, improved access to care, and a growing number of diagnoses. Government programs and NGO support have motivated more individuals to pursue treatment. Canada is ideally situated for market expansion due to its robust healthcare system and diverse treatment alternatives, such as medications and therapy. Elements such as stress, changes in lifestyle, and substance misuse are additionally driving the need for bipolar disorder therapies in the nation.
Asia-Pacific is anticipated to grow at the fastest rate in the market during the forecast period, driven by several key factors. Rising awareness of mental health concerns and the greater acceptance of care are resulting in increased diagnosis rates. Economic development and enhanced healthcare infrastructure are increasing access to mental health services throughout the region. Urbanization, elevated stress levels, and growing substance abuse are leading to a rise in bipolar disorder occurrences. Moreover, initiatives by the government and NGOs aimed at raising mental health awareness are increasing the need for effective treatments. These elements together are poised to drive fast market growth in the region.
In China, the bipolar disorder market secured a considerable portion, fueled by the existence of key manufacturing sectors and a strong distribution framework. Quick urban growth, healthcare infrastructure, strategic collaboration, and increasing stress levels have led to a rise in mental health diagnoses in the population. Moreover, governmental actions and an increased number of drug authorizations have played a role in the ongoing expansion of the market in the nation.
The market for bipolar disorder treatment in India is expanding quickly due to a greater understanding and acceptance of mental health conditions. Bipolar disease and other mental health disorders are becoming more common as a result of changing social standards, hectic lives, and increasing urbanization. More individuals are seeking treatment as a result of government programs and campaigns to raise awareness of mental health issues. The market is also expanding as a result of advancements in healthcare infrastructure and the accessibility of a variety of treatment alternatives, such as medicine and therapy. The market in India is being further stimulated by the expanding availability of medical services and the growing acceptability of mental health treatment.
Europe is observed to grow at a considerable growth rate in the upcoming period, driven by a rising prevalence of the condition and greater awareness of mental health. Rapid urbanization, lifestyle changes, and more stressful environments have led to unhealthy habits and an increase in mental health diagnoses, including bipolar disorder. As more individuals seek to assess their mental well-being, the demand for treatment has grown. Additionally, the presence of major pharmaceutical companies offering a range of medications for bipolar disorder has further supported market growth in the region.
The UK market for bipolar disorder treatment is experiencing positive growth due to increased awareness of mental health issues and better access to treatment alternatives. With an increasing number of people being diagnosed with bipolar disorder, the need for effective medications, such as mood stabilizers and antipsychotics, has grown. The growing acceptance of mental health care and the incorporation of mental health services into primary care has also aided in market growth. Moreover, the presence of advanced therapies, combined with government programs and mental health awareness campaigns, has motivated a greater number of individuals to pursue professional help, thereby fueling the expansion of the market in the UK.
The market for treating bipolar disorder in France is growing because of various distinctive elements. Innovations in medical technology, including digital therapeutics and telemedicine, are enhancing the accessibility and personalization of treatment for patients. France's increasing emphasis on incorporating mental health into public health policies has resulted in a rise in funding for the research and development of new treatments for bipolar disorder. Moreover, an increased focus on early intervention and preventive care is fostering early diagnoses, resulting in more patients pursuing prompt treatment. The increasing presence of support networks and mental health advocacy groups in France is aiding in diminishing stigma and promoting treatment-seeking actions.
“Bipolar disorder is a complex condition, with depression often posing the greatest burden for patients.” “This clinical trial marks a significant step forward in exploring innovative, much-needed treatments for bipolar disorder.” If proven effective, this has the potential to provide significant benefits to patients by helping effectively manage their symptoms and improving their overall quality of life, Said Dr. Lakshmi Yatham, professor and head of UBC’s Department of Psychiatry.
By Drug Class
By Distribution Channel
By Region
February 2025
January 2025
January 2025
October 2024